2021
Monitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination
Oliveira CR, Niccolai LM. Monitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination. Preventive Medicine 2021, 144: 106363. PMID: 33678234, PMCID: PMC8582276, DOI: 10.1016/j.ypmed.2020.106363.Commentaries, Editorials and LettersConceptsCervical cancer eliminationCancer eliminationHPV vaccineCervical cancerImportant public health goalHPV vaccine impactPost-licensure monitoringPopulation-level burdenProlonged latency periodImportant public health activityPublic health activitiesPublic health goalsHPV vaccinationCervical infectionCervical diseaseVaccine impactInvasive diseaseLatency periodConvincing benefitHealth goalsHealth activitiesVaccineDiseaseUrgent research priorityCancer
2019
Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis
Avni-Singer LR, Yakely A, Sheth SS, Shapiro ED, Niccolai LM, Oliveira CR. Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis. Public Health 2019, 178: 137-150. PMID: 31698136, PMCID: PMC6994345, DOI: 10.1016/j.puhe.2019.08.010.Peer-Reviewed Original ResearchConceptsHPV vaccineVaccine impact studiesSociodemographic disparitiesSystematic reviewImportant public health priorityHPV vaccine eraReduction of HPVPopulation-level burdenPublic health priorityPubMed/MEDLINEScience Citation IndexHPV infectionGenital wartsSocio-economic subgroupsCervical dysplasiaRoutine vaccinationVaccine eraVaccine impactCitation IndexHuman papillomavirusVaccine introductionSentinel surveillanceStudy protocolEligible studiesHealth priorityHuman papillomavirus vaccination and anogenital warts
Yakely AE, Avni-Singer L, Oliveira CR, Niccolai LM. Human papillomavirus vaccination and anogenital warts. Sexually Transmitted Diseases 2019, Publish Ahead of Print: &na;. PMID: 30461595, PMCID: PMC6640846, DOI: 10.1097/olq.0000000000000948.Peer-Reviewed Original ResearchConceptsAnogenital wartsAge 25 yearsHPV vaccineEffectiveness studiesHPV vaccine impactHuman papillomavirus vaccinationPre-vaccine eraMale vaccinationPapillomavirus vaccinationVaccination historyVaccine impactVaccine introductionFemale vaccinationEmbase databasesVaccination programEligible studiesExclusion criteriaLower riskVaccineVaccinationWartsPrevention potentialReal-world benefitsFemalesUnited States